In this project, our team provides malaria vaccine impact predictions to inform vaccine investment strategies for Gavi, the Vaccine Alliance, and their partners. We do this by making predictions of the potential health impact of products such as the RTS,S and R21 vaccines, using our model, OpenMalaria. We provide these estimates of malaria vaccine impact for over 26 African countries. This is a recurrent analysis with multiple touchstones throughout the year.
Paper: Gaythorpe, K. A., Li, X., Shankar, M., Hartner, A. M., Gibney, Z., ... & Trotter, C. L. (2026). Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study. The Lancet, 407(10542), 1941-1952.
Vaccine Impact Modelling Consortium (VIMC) supporting Gavi, the Vaccine Alliance
In this project, our team provides malaria vaccine impact predictions to inform vaccine investment strategies for Gavi, the Vaccine Alliance, and their partners.